2023 Spring Meeting Preliminary ProgramTHURSDAY, JUNE 22
|
YASOPRS Eye-Openers | ||
Moderators: Vinay Aakalu, Ana Carolina Victoria | ||
7:30-7:31 am | Introduction of Session by Moderators | |
7:31-7:35 | The Flipped-T Flap for Floppy Eyelid Entropion Repair | Kally |
7:35-7:39 | Opioids use in the management of postoperative pain after orbital fracture repairs | Park |
7:39-7:43 | Osteolytic Orbital Lesions in Sarcoidosis |
Larochelle |
7:43-7:47 | Cutaneous Leishmaniasis of the Eyelid | Mudie |
7:47-7:51 | Medial Canthal Eccrine Poroma with Invasion of the Nasal Cavity | Ray |
7:51-8:00 | Q & A | |
8-8:02 | Welcome | Steele/Allen |
Advocacy Session | ||
Moderators: Stuart Seiff | ||
8:02-8:04 am | Introduction of Session | Steele |
8:04-8:06 | Dedication of lecture | |
8:06-8:08 | Introduction of Cathy Cohen | |
8:08-8:23 | FEATURED SPEAKER: Ophthalmology Advocacy Past, Present and Future: The Power of Relationships" | Catherine Cohen |
8:23-8:30 | ASOPRS advocacy update | Seiff |
8:30-8:40 | Panel Discussion: Cohen, Seiff, Shriver | |
Orbit Session | ||
Matthew G. Vicinanzo and Neda Esmaili | ||
8:40-8:41 am | Introduction of session by moderators | |
8:41-8:47 | Return to Sport Among Professional Athletes After Orbital Fracture | Vaishnav |
8:47-8:53 | Adjunctive Use of Umbilical Amnion in Corneal Neurotization Surgery for Neurotrophic Keratitis: A Case Series | Chung |
8:53-8:59 | Clinical and radiographic features of idiopathic skull base inflammatory disease | Pirakitikulr |
8:59-9:05 | Trends in the Incidence of Orbital Cellulitis at a Large Pediatric Tertiary Care Center Spanning the Covid-19 Pandemic | Vloka |
9:05-9:14 | Q & A | |
9:14-9:20 | Optic nerve sheath fenestration: a retrospective review of safety, efficacy, and utility of optical coherence tomography | Gupta |
9:20-9:26 | Hydrogen Peroxide as a Modality for Hemostasis in Orbital Surgery | Nabavi |
9:26-9:32 | Cushing’s of the orbit: a rare but vision-threatening clinical scenario | Simmons |
9:32-9:38 | Retrospective Case Series of Conservative Management for Chronically Inflamed Anophthalmic Sockets with Pegged Integrated Orbital Implants | Nassrallah |
9:38-9:50 | Q & A | |
9:50-10:20 am | Break with Exhibitors | |
Physician Payment Reform Session | ||
Moderators: Stuart R. Seiff | ||
10:20-10:21 am | Introduction of Session | Steele |
10:21-10:36 | Physician Payment Reform | Catherine Cohen |
10:36-10:44 | Panel Discussion: Cohen, Seiff, Shriver | |
Aesthetic Session | ||
Moderators: Lora Dagi Glass and Cameron B. Nabavi | ||
10:44-10:45 am | Introduction of Session by Moderators | |
10:45-10:51 | The First Reported Case of Vision Loss Secondary to Arterial Vascular Occlusion After Filler Injection Into the Lip Only and A Novel Treatment Technique | Keenum |
10:51-10:57 | Medical Spa Referral Sources | Wu |
10:57-11:03 | USE OF AUTOLOGOUS HUMAN FIBROBLASTS IN THE MANAGEMENT OF FACIAL SCARS | Plazola |
11:03-11:09 | High dose tetracycline injection for the treatment of malar and lower eyelid edema | Ray |
11:09-11:22 | Q & A | |
Eyelid Session | ||
Moderators: Catherine J. Hwang and Gil A. Epstein | ||
11:22-11:23 am | Introduction of Session by Moderators | |
11:23-11:29 | Clinical outcomes of corneal neurotization with and without topical cenegermin in the treatment of neurotrophic keratitis | Park |
11:29-11:35 | Decellularized fish skin for treatment of periocular skin defect | Maliakkal |
11:35-11:41 | Ptosis Practice Patterns Among ASOPRS Members | Wu |
11:41-11:47 | Retrospective chart review to evaluate a novel botulinum toxin injection pattern for treatment of blepharospasm and hemifacial spasm | Bersani |
11:47-12 pm | Q & A |
YASOPRS Eye-Openers | ||
Moderators: Sandy X. Zhang-Nunes and Femida Kherani | ||
7:30-7:31 am | Introduction of Session by Moderators | |
7:31-7:35 | Metastatic esophageal adenocarcinoma presenting as a painful orbital mass with myopathy | Ray |
7:35-7:39 | Retrobulbar Amphotericin for Severe Vision Loss in an Immunocompetent Patient with Invasive Fungal Rhino-Orbital Sinusitis After Routine Functional Endoscopic Sinus Surgery | Ahmad |
7:39-7:43 | Checkpoint Inhibitor-Related Ophthalmic Adverse Events | Akella |
7:43-7:47 | Aggressive ulcerative fungal dacryocystitis presenting as an infiltrative sinonasal mass | Parikh |
7:47-7:51 | Ophthalmic Morgellons Disease | Pirakitikulr |
7:51-8:00 | Q & A | |
8:00- 8:01 am | Welcome Day 2 | Steele |
Thyroid Session | ||
Moderators: Christina Choe and Greg J. Griepentrog | ||
8-8:01 am | Introduction of Session by Moderators | |
8:01-8:07 | Adverse events of teprotumumab in advanced age patients, a multi-center study | Kossler |
8:07-8:13 | Evaluation of OCT Angiography and Orbital Decompression | Punja |
8:13-8:19 | Low Dose Orbital Radiotherapy for Graves’ Ophthalmopathy Does Not Cause Radiation Retinopathy | Watson |
8:19-8:25 | Updated Association between Teprotumumab Use and Hearing Impairment | Vicinanzo |
8:25-8:35 | Q & A | |
Oncology Session | ||
Moderators: Daniel E. Buerger and Natalie A. Stanciu | ||
8:35-8:36 am | Introduction of Session by Moderators | |
8:36-8:42 | Resection of Zygomatic Intraosseous Hemangioma and Reconstruction with Patient-Specific Implant | Cho |
8:42-8:48 | Corneal Neurotization in Patients with Skull Base Tumors and in the Setting of Radiation Therapy | Esmaeli |
8:48-8:54 | Risk Factors for Periocular and Orbital Complications Among Patients with Malignant Sinonasal Tumors and Secondary Orbital Invasion Managed with Eye-Sparing Surgeries | Zhao |
8:54-9:00 | Fluorescent marker for identification of adenoid cystic carcinoma cells | Stevens |
9:00-9:10 | Q & A | |
State Affairs Session | ||
9:10-9:11 am | Introduction of Session | Steele |
9:11-9:14 | Slido Poll | |
9:14-9:24 | Why Advocate? How You and ASOPRS can make a difference | Shriver |
9:24-9:35 | Q & A: Shriver, Seiff | |
9:35-10:05 | Break with Exhibitors | |
SASOPRS Tough Cases Master Panel | ||
Moderator: David R. Jordan | ||
10:05-10:06 | Introduction of Session by Moderator | |
10:06-11 | Tough Cases Master Panel cases | |
Panelists: Christine Nelson, Bita Esmaeli, John Shore, James Fleming | ||
The Unhappy Patient Session with OMIC | ||
Moderator: Tamara R. Fountain | ||
11-11:01 am | Introduction by Moderator | |
11:01-11:45 | The Unhappy Patient | |
Panelists: Linda Harrison, Elizabeth Bradley, Ted Wojno, Keith Carter, Don Kikkawa | ||
11:45 am - 12 pm | ASOPRS Awards |
M&M Session | ||
Moderators: John D. Ng and N. Grace Lee | ||
8:00-8:01 am | Introduction of Session by Moderators | |
8:01-8:07 | Septic cavernous sinus thrombosis mimicking necrotizing fasciitis: a management dilemma | Chen |
8:07-8:13 | Ocular Trigeminal Trophic Syndrome Following Cranial Nerve VI Schwannoma Resection and Herpes Zoster Varicella Infection: A case series of trigeminal trophic syndrome causing extensive ocular surface destruction | Shebaclo |
8:13-8:19 | Fatal Oedipism: A Case Report and Literature Review | Gupta |
8:19-8:25 | A recalcitrant zipper to an upper lid | Mudie |
8:25-8:35 | Q & A | |
Lacrimal Session | ||
Moderators: Louise A. Mawn and Dianne M. Schlachter | ||
8:35-8:36 am | Introduction of Session by Moderators | |
8:36-8:42 | Concurrent dacryocystorhinostomy and saddle nose deformity repair in a patient with granulomatosis with polyangiitis | Ray |
8:42-8:48 | Bilateral Dacryocystoceles in Congenital Arhinia: A Case Report | Lin |
8:48-8:54 | Preventing Jones Tube Migration: A Suture Fixation Technique | Keenum |
8:54-9:00 | Use of acellular dermal allograft as orbital support following oncocytoma resection with canalicular sparing | Parikh |
9:00-9:10 | Q & A | |
9:10-9:40 | Break with Exhibitors | |
Pediatrics Session | ||
Moderators: Suzanne van Landingham and Thomas Bersani | ||
9:40-9:41 am | Introduction of Session by Moderators | |
9:41-9:47 | Orbital Cellulitis with Complex Sinusitis and Empyema: Trends in Incidence, Complexity, and Epidemiology After the COVID-19 Pandemic | Crawford |
9:47-9:53 | Orbital Rhabdomyosarcoma in a Pediatric Patient with Costello Syndrome | Nassrallah |
9:53-9:59 | Periocular Rabies Exposure: A Case Report and Review of Current Recommendations | Noguera |
9:59-10:05 | Watchful waiting of intramuscular orbital lymphaticovenous malformations: a case series | Dallalzadeh |
10:05-10:15 | Q & A | |
10:15-10:18 | ASOPRS Foundation YASOPRS Rising Star Award | Holds |
10:18-10:20 am | Closing remarks | Allen/Steele |
Catherine Grealy Cohen launched her own firm, Strategies for Innovative Policy Solutions on April 1 after stepping down from her longstanding position of vice president for governmental affairs for the American Academy of Ophthalmology. With more than twenty-five years in the position and more than 40 years in governmental relations, Ms. Cohen has played significant roles in affecting physician payments under Medicare, ensuring appropriate eye care for veterans, as well as the successful passage of the first blindness prevention benefit under Medicare for detection of glaucoma.
With a passion for disruptive technology, Catherine is interested in continuing work related to Medicare coverage and payment in the AI space, remote therapeutic monitoring, and genomics.
Prior to her position with the Academy, Ms. Cohen served as director of federal affairs at Eastman Kodak Company, where she helped establish an employee political action committee (PAC) for the 100-year-old company and coordinated the grassroots program. She initially served as director of health affairs, coordinating development of Kodak’s health care reform position for use at both the state and federal level. She also reported to the president of Kodak’s medical device company and acted as their lobbyist, helping to repeal a law and change regulations that disadvantaged the company. Before her tenure at Kodak, Ms. Cohen was director of the American Society of Clinical Pathologist’s Washington office where she supervised the organization’s federal and state lobbying efforts and helped pass the Clinical Laboratory Improvement Act and Stark law. She started her lobbying career with the Academy in 1979 after four years on Capitol Hill.
Ms. Cohen earned a master’s degree in health services administration from George Washington University and is widely published on Medicare reimbursement, legislative and regulatory issues.
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education through the American Society of Ophthalmic Plastic & Reconstructive Surgery. The American Society of Ophthalmic Plastic & Reconstructive Surgery is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The American Society of Ophthalmic Plastic and Reconstructive Surgery designates this live activity for a maximum of 10 (estimated) AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.